971 filings
Page 2 of 49
POS AM
SRNEQ
Sorrento Therapeutics, Inc.
21 Jun 23
Prospectus update (post-effective amendment)
5:24pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
20 Jun 23
Regulation FD Disclosure
5:01pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
15 Jun 23
Regulation FD Disclosure
9:41am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
18 May 23
Regulation FD Disclosure
9:23pm
10-Q
2023 Q1
SRNEQ
Sorrento Therapeutics, Inc.
Quarterly report
15 May 23
3:16pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
15 May 23
Regulation FD Disclosure
12:03pm
POS AM
SRNEQ
Sorrento Therapeutics, Inc.
12 May 23
Prospectus update (post-effective amendment)
5:28pm
NT 10-Q
SRNEQ
Sorrento Therapeutics, Inc.
8 May 23
Notice of late quarterly filing
9:04pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
2 May 23
Regulation FD Disclosure
7:33pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
25 Apr 23
Regulation FD Disclosure
7:21pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
20 Apr 23
Other Events
5:26pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
20 Apr 23
Other Events
12:08pm
25-NSE
The Nasdaq Stock Market LLC
12 Apr 23
Exchange delisting
8:50am
8-K/A
SRNEQ
Sorrento Therapeutics, Inc.
10 Apr 23
Other Events
5:22pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
10 Apr 23
Other Events
3:15pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
30 Mar 23
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
9:39pm
4
Ji Henry
20 Mar 23
Sorrento Therapeutics / Henry Ji ownership change
7:52pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
17 Mar 23
Court Confirms Sorrento Therapeutics, Inc.’s $125 Million Arbitration Award Against NantPharma, LLC
6:37pm
10-K
2022 FY
SRNEQ
Sorrento Therapeutics, Inc.
Annual report
15 Mar 23
6:41pm
SC 13G/A
SRNEQ
Sorrento Therapeutics, Inc.
10 Mar 23
Sorrento Therapeutics / STATE STREET ownership change
11:21am